Hikma completes Xellia acquisitionThe acquisition includes a commercial portfolio and pipeline of differentiated products, a manufacturing facility in Cleveland, Ohio, sales and marketing capabilities and an R&D center in Zagreb, Croatia. Patrick Soon-Shiong joins Avenacy Soon-Shiong brings more than 25 years of pharmaceutical industry experience, including successful commercialization of injectable generic drugs. Upsher-Smith selects PANTHERx Rare to distribute Torpenz Torpenz Tablets are used for the treatment of Tuberous Sclerosis Complex. Mallinckrodt to sell Therakos business to CVC for $925M Therakos is a fully integrated extracorporeal photopheresis delivery system for autologous immunomodulatory therapy. Upsher-Smith intros Torpenz Torpenz is an oral mTOR inhibitor used in patients with tuberous sclerosis complex. Walgreens Specialty Pharmacy earns accreditations from URAC, ACHC The accreditations reinforce the company’s commitment to serving patients with utmost quality and care. Report finds increase in specialty drug trend, spend Specialty drug spend and trend rose in 2023, per the latest PSG report. Meitheal Pharmaceuticals acquires Contepo from Nabriva Therapeutics Contepo is an intravenous broad-spectrum antibiotic for treating multi-drug resistant strains that cause urinary tract infections. Lupin divests U.S. commercial women's health specialty business to Evofem Lupin's U.S. commercial women's health specialty business is primarily focused on commercializing Solosec 2 g oral granules. Avenacy releases magnesium sulfate in water for injection Magnesium sulfate in water for injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia. First Previous 1 2 3 4 5 Next Last
